HAEMONETICS CORP - Common Stock (HAE)

Historical Holders from Q1 2014 to Q3 2025

Symbol: HAE on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 47,898,935
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 51,316,369
Holdings value: $2,500,012,174
% of all portfolios: 0.003%
Number of holders: 295
Number of buys: 149
Number of sells: -170
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of HAEMONETICS CORP - Common Stock (HAE)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
WELLINGTON MANAGEMENT GROUP LLP	4.6%	-16%	$165,537,761	-$36,448,193	2,203,351	-18%	Wellington Management Group LLP	30 Jun 2025
T. Rowe Price Investment Management, Inc.	4.4%		$135,949,632		2,195,569		T. Rowe Price Investment Management, Inc.	31 Mar 2025
Capital Research Global Investors	3.1%		$97,667,840		1,577,323		Capital Research Global Investors	31 Mar 2025

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	51,316,369	$2,500,012,174	-$235,189,916	$19,245,976	$31,393,984	$48.74	295
2025 Q2	54,253,774	$4,048,407,950	+$51,089,014	$5,197,725	$21,057,968	$74.61	297
2025 Q1	53,724,229	$3,412,895,600	-$212,763,194	$19,933,331	$25,110,317	$63.55	313
2024 Q4	56,558,011	$4,415,683,452	+$40,389,204	$36,990,070	$42,010,984	$78.08	305
2024 Q3	55,858,330	$4,486,624,929	-$21,003,128	$44,948,076	$46,880,162	$80.38	303
2024 Q2	55,851,715	$4,621,294,419	+$385,980,667	$3,731,123	$29,789,838	$82.73	315
2024 Q1	51,176,074	$4,367,618,453	+$50,781,270	$4,805,205	$13,715,555	$85.35	296
2023 Q4	50,568,886	$4,325,205,912	-$20,996,057	$4,766,977	$11,112,700	$85.51	294
2023 Q3	50,792,206	$4,551,407,114	+$20,351,169	$2,218,018	$17,865,973	$89.58	294
2023 Q2	50,542,703	$4,303,570,562	+$14,249,115	$2,205,126	$8,380,125	$85.14	288
2023 Q1	50,384,868	$4,169,004,070	+$9,612,280	$4,768,487	$8,192,975	$82.75	294
2022 Q4	50,382,562	$3,963,254,277	-$107,357,997	$7,431,640	$2,485,075	$78.65	287
2022 Q3	51,775,808	$3,833,648,345	-$28,085,090	$5,072,000	$3,701,000	$74.03	260
2022 Q2	52,080,593	$3,394,785,256	+$49,689,135	$13,447,000	$10,598,000	$65.18	229
2022 Q1	51,567,377	$3,257,869,910	+$120,748,445	$1,745,000	$3,190,000	$63.22	225
2021 Q4	50,084,803	$2,655,680,021	-$87,203,336	$3,723,000	$15,538,000	$53.04	240
2021 Q3	50,697,310	$3,576,779,438	+$7,330,940	$21,071,500	$16,743,998	$70.59	239
2021 Q2	50,672,122	$3,375,443,272	-$52,557,812	$18,145,000	$18,196,000	$66.64	249
2021 Q1	49,961,531	$5,549,106,460	-$22,300,347	$5,850,000	$10,723,000	$111.01	288
2020 Q4	49,701,181	$5,902,338,582	+$13,637,273	$16,020,000	$12,814,000	$118.75	278
2020 Q3	49,419,749	$4,312,359,704	-$6,823,951	$8,725,000	$13,695,000	$87.25	261
2020 Q2	49,513,911	$4,436,797,359	-$134,065,133	$29,084,000	$7,762,000	$89.56	276
2020 Q1	50,595,124	$5,040,192,796	+$54,162,521	$13,743,000	$10,514,000	$99.66	263
2019 Q4	49,844,997	$5,726,892,199	-$8,413,468	$230,000	$2,011,000	$114.9	291
2019 Q3	49,617,874	$6,258,106,643	-$157,378,824	$16,058,000	$7,530,000	$126.14	271
2019 Q2	50,896,394	$6,124,009,590	+$58,035,871	$2,130,000	$1,071,000	$120.34	253
2019 Q1	51,283,498	$4,486,016,605	+$62,307,595	$962,000	$3,412,000	$87.48	253
2018 Q4	50,443,395	$5,047,277,313	-$147,988,434	$2,281,000	$790,000	$100.05	277
2018 Q3	51,715,308	$5,924,362,043	+$210,608,325	$4,354,000	$3,299,000	$114.58	289
2018 Q2	50,368,130	$4,517,192,617	-$185,243,709	$15,291,000	$1,148,000	$89.68	289
2018 Q1	52,583,034	$3,847,182,644	+$17,637,230	$0	$1,046,000	$73.16	254
2017 Q4	53,625,853	$3,115,125,238	-$26,066,940	$1,400,000	$889,000	$58.08	240
2017 Q3	54,786,766	$2,458,102,091	-$29,442,951			$44.87	203
2017 Q2	55,471,370	$2,190,580,845	+$31,076,045			$39.49	190
2017 Q1	54,635,388	$2,216,655,714	+$337,134,900	$0		$40.57	176
2016 Q4	52,451,093	$2,108,521,648	+$26,285,233	$486,000	$0	$40.2	192
2016 Q3	51,805,572	$1,875,274,739	+$32,082,627		$449,000	$36.21	176
2016 Q2	50,973,144	$1,478,067,581	-$32,032,171		$249,000	$28.99	169
2016 Q1	51,250,356	$1,791,862,985	+$9,515,385			$34.98	160
2015 Q4	51,190,608	$1,650,317,369	-$35,481,356			$32.24	158
2015 Q3	52,124,856	$1,684,666,056	-$42,369,690			$32.32	168
2015 Q2	53,401,411	$2,208,658,190	-$15,026,392	$0	$0	$41.36	176
2015 Q1	53,751,288	$2,413,804,087	-$14,774,340	$238,000	$463,000	$44.92	166
2014 Q4	54,180,608	$2,027,372,717	+$29,529,104			$37.42	171
2014 Q3	53,079,424	$1,853,545,493	-$47,792,045			$34.92	168
2014 Q2	54,462,831	$1,921,442,064	+$18,983,073	$0	$0	$35.28	172
2014 Q1	54,173,562	$1,765,475,443	-$102,994,220	$1,340,000	$411,000	$32.59	187